Singapore markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9810+0.0709 (+7.78%)
As of 11:43AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
126,847
126,325
7,128
144,927
33,215
-
Operating expenses
Research development
123,593
145,860
172,920
141,891
90,570
-
Selling general and administrative
80,740
87,744
79,694
69,261
30,775
-
Total operating expenses
203,848
234,308
253,618
209,420
121,345
-
Operating income or loss
-77,001
-107,983
-246,490
-64,493
-88,130
-
Interest expense
15,891
13,176
6,020
2,910
2,924
-
Total other income/expenses net
2,292
134
-705
-1,045
981
-
Income before tax
-82,683
-113,724
-250,157
-65,578
-89,127
-
Income from continuing operations
-82,683
-113,724
-250,157
-65,578
-89,127
-
Net income
-82,683
-113,724
-250,157
-65,578
-89,127
-
Net income available to common shareholders
-82,683
-113,724
-250,157
-65,578
-89,127
-
Basic EPS
-1.11
-
-2.31
-0.72
-1.12
-1.24
Diluted EPS
-1.11
-
-2.31
-0.72
-1.12
-1.24
Basic average shares
126,765
-
108,077
91,703
79,789
56,649
Diluted average shares
126,765
-
108,077
91,703
79,789
56,649